DFDine J. Feenstra

Dine J. Feenstra

*This is an algorithmically generated author record based on publicly available information.

Dine J. Feenstra has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Community-Based Treatment of Families with Adolescents with an Autism Spectrum Disorder (Level 1): Two Single Case Experimental Design Studies on the Effects of Multisystemic Therapy

    by A. M. M. M. Blankestein, A. M. C. Lange, D. J. Feenstra, M. J. M. H. Delsing

    Background: Families of adolescents with severe behavior problems and an Autism Spectrum Disorder (ASD) level 1 may experience a variety of problems in their functioning. Research suggests that these problems across multiple life areas are best treated with intensive, flexible, and home-based treatment such as Multisystemic Therapy (MST). However, little is known about the treatment results of MST for families of autistic adolescents. OBJECTIVE: In two Single Case Experimental Design (SCED) studies ( N = 14 families), the treatment outcomes and effects of MST were assessed. Methods: An observational AB study design was employed. Families receiving treatment as part of two cohorts were asked to participate in the two studies. Results: Overall, some positive changes were observed during MST treatment. Of 22 parents, 8 parents showed significant improvement based on the Reliable Change Index. Tau-U analyses used in both studies reveal that there was little evidence of treatment effect, despite families reporting positive experiences with treatment during interviews. A meta-analysis of Tau-U scores revealed no overall effect for the total study population and a small effect for mothers. Conclusions: Little treatment effect was observed in these SCED studies. When changes or effects were observed following MST treatment, these tended to be positive. To reach firmer conclusions, a larger and more robust study would be needed. More research is also needed to attain a better understanding of how to best support families of young autistic people.

  • Attachment as a predictor of dropout in mentalization‐based treatment

    by Melissa G. A. Remeeus, Maaike L. Smits, Anna M. Bal‐Bax, Dine J. Feenstra, Patrick Luyten

    Objectives: Although treatments of patients with borderline personality disorder (BPD) were historically associated with relatively high dropout rates, dropout rates in contemporary evidence‐based treatments for BPD are typically substantially lower. However, only a few studies have investigated dropout rates in mentalization‐based treatment (MBT), and even fewer have investigated predictors of dropout in this type of treatment. In this study, we investigated dropout rates in two types of MBT (day hospital MBT [MBT‐DH] and intensive outpatient MBT [MBT‐IOP]) using data from a recent multicenter randomized clinical trial. Given the central importance of attachment considerations in MBT, we also investigated the relationship between dropout in these two treatments and attachment dimensions. Design: Within a multicenter randomized clinical trial, 114 BPD patients were randomized to MBT‐DH ( n = 70) or MBT‐IOP ( n = 44). Methods: Dropout in both types of MBT was investigated using descriptive analyses, and its association with attachment anxiety and attachment avoidance, as measured by the Experiences in Close Relationships questionnaire at baseline, was investigated using regression analyses. Results: Dropout rates were relatively low (10.5% across both types of MBT) and did not significantly differ between groups (11.4% in MBT‐DH, 9.1% in MBT‐IOP). Attachment avoidance and attachment anxiety did not impact dropout, nor did their interaction or the interaction with the type of MBT. Conclusions: Low dropout rates in both types of MBT indicate a high level of engagement of patients in both programmes. Attachment dimensions were not associated with dropout, consistent with the principle that MBT is tailored to each individual's needs. More research is needed, however, to investigate to what extent attachment is a dynamic context‐bound adaptive process rather than a static personality feature.


  • Economic evaluation of day hospital versus intensive outpatient mentalization-based treatment alongside a randomized controlled trial with 36-month follow-up.

    by Matthijs Blankers, Maaike L. Smits, Dine J. Feenstra, Eva K. Horn, Jan Henk Kamphuis, Dawn L. Bales, Zwaan Lucas, Melissa G. A. Remeeus, Jack J. M. Dekker, Roel Verheul, et al.

    Mentalization-based treatment (MBT) has demonstrated robust effectiveness in the treatment of borderline personality disorder (BPD) in both day-hospital (MBT-DH) and intensive outpatient MBT (MBT-IOP) programs. Given the large differences in intensity and associated treatment costs, there is a need for studies comparing their cost-effectiveness. A health economic evaluation of MBT-DH versus MBT-IOP was performed alongside a multicenter randomized controlled trial with a 36-month follow-up. In three mental health-care institutions in the Netherlands, 114 patients were randomly allocated to MBT-DH (n = 70) or MBT-IOP (n = 44) and assessed every 6 months. Societal costs were compared with quality-adjusted life years (QALYs) gained and the number of months in remission over 36 months. The QALY gains over 36 months were 1.96 (SD = .58) for MBT-DH and 1.83 (SD = .56) for MBT-IOP; the respective number of months in remission were 16.0 (SD = 11.5) and 11.1 (SD = 10.7). Societal costs were €106,038 for MBT-DH and €91,368 for MBT-IOP. The incremental cost for one additional QALY with MBT-DH compared with MBT-IOP was €107,000. The incremental cost for 1 month in remission was almost €3000. Assuming a willingness-to-pay threshold of €50,000 for a QALY, there was a 33% likelihood that MBT-DH is more cost-effective than MBT-IOP in terms of costs per QALY. Although MBT-DH leads to slightly more QALYs and remission months, it is probably not cost-effective when compared with MBT-IOP for BPD patients, as the small additional health benefits in MBT-DH did not outweigh the substantially higher societal costs. (PsycInfo Database Record (c) 2023 APA, all rights reserved).


  • Assessing DSM–5-oriented level of personality functioning: Development and psychometric evaluation of the Semi-Structured Interview for Personality Functioning DSM–5 (STiP-5.1).

    by Joost Hutsebaut, Jan H. Kamphuis, Dine J. Feenstra, Laura C. Weekers, Hilde De Saeger

    The alternative model for personality disorders (AMPD) in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) features a Level of Personality Functioning Scale, measuring intrinsic personality processes that include identity, self-direction, empathy, and intimacy. This study describes the development and psychometric evaluation of a semistructured interview schedule for the multi-item assessment of the level of personality functioning, the Semi-Structured Interview for Personality Functioning DSM-5 (STiP-5.1). Eighty patients and 18 community subjects completed the STiP-5.1. Patients additionally completed the Brief Symptom Inventory, the Severity Indices of Personality Problems, and the Structured Clinical Interview for DSM-IV Axis I and Axis II Personality Disorders. Good interrater reliability was observed in subsamples of patients (n = 40) and nonpatients (n = 18). Associations between the interview scores and conceptually relevant external measures consistently supported the construct validity of the instrument. The STiP-5.1 thus offers a brief, relatively user-friendly instrument with generally favorable psychometric properties for the assessment of level of personality functioning of the DSM-5 AMPD. (PsycINFO Database Record


  • Therapeutic assessment promotes treatment readiness but does not affect symptom change in patients with personality disorders: Findings from a randomized clinical trial.

    by Hilde De Saeger, Jan H. Kamphuis, Stephen E. Finn, Justin D. Smith, Roel Verheul, Jan J. van Busschbach, Dine J. Feenstra, Eva K. Horn

    The field of clinical personality assessment is lacking in published empirical evidence regarding its treatment and clinical utility. This article reports on a randomized controlled clinical trial (N = 74) allocating patients awaiting treatment in a specialized clinic for personality disorders to either 4 sessions of (a) therapeutic assessment (TA) or (b) a structured goal-focused pretreatment intervention (GFPTI). In terms of short-term outcome, TA demonstrated superior ability to raise outcome expectancies and patient perceptions of progress toward treatment (Cohen's d = 0.65 and 0.56, respectively) and yielded higher satisfaction (d = 0.68). Moreover, patients reported marginally stronger alliance to the TA clinicians than to GFPT clinicians (d = 0.46), even though therapists perceived the alliance as equally positive in both groups. No differences in symptomatic ratings were observed. Results are discussed with reference to treatment utility in this particular patient group.